[HTML][HTML] European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease
S Grozinsky‐Glasberg, J Davar, J Hofland… - Journal of …, 2022 - ncbi.nlm.nih.gov
1. MATERIALS AND METHODS Data regarding the diagnosis, management, and follow‐up
of carcinoid syndrome (CS) and carcinoid heart disease (CHD) were identified by searches …
of carcinoid syndrome (CS) and carcinoid heart disease (CHD) were identified by searches …
Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration
S Das, SS Stockton, SA Hassan - The Oncologist, 2023 - academic.oup.com
Carcinoid heart disease (CaHD) is an important complication among patients with metastatic
neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually …
neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually …
Carcinoid heart disease in patients with midgut neuroendocrine tumours
C Delhomme, T Walter, D Arangalage… - Journal of …, 2023 - Wiley Online Library
Carcinoid heart disease (CHD) is the main complication of carcinoid syndrome (CS)
associated with metastatic small intestine neuroendocrine tumours (NETs). The …
associated with metastatic small intestine neuroendocrine tumours (NETs). The …
[HTML][HTML] Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a …
DJ Monlezun, A Badalamenti, A Javaid… - Frontiers in …, 2023 - frontiersin.org
Background Carcinoid heart disease is increasingly recognized and challenging to manage
due to limited outcomes data. This is the largest known cohort study of valvular pathology …
due to limited outcomes data. This is the largest known cohort study of valvular pathology …
[HTML][HTML] Prevalence, one-year-incidence and predictors of carcinoid heart disease
I Mattig, MR Franke, R Pschowski, A Brand… - Cardiovascular …, 2023 - Springer
Background Carcinoid heart disease (CHD) caused by neuroendocrine tumours (NET) is
associated with an increased morbidity and mortality due to valvular dysfunction and right …
associated with an increased morbidity and mortality due to valvular dysfunction and right …
Improving outcomes in carcinoid heart disease–learning from a single centre
J Cope, R Maclean, S Hota, JK Ramage… - Nuclear Medicine …, 2023 - journals.lww.com
Results Twenty-six patients underwent valve replacement. Mean (SD) age was 61 (11)
years, 54% female. Eleven tumours were grade G1, with the remaining G2. NYHA pre …
years, 54% female. Eleven tumours were grade G1, with the remaining G2. NYHA pre …
[HTML][HTML] The Role of Transthoracic Echocardiography for Assessment of Mortality in Patients with Carcinoid Heart Disease Undergoing Valve Replacement
A Brooke, S Porter-Bent, J Hodson, R Ahmad… - Cancers, 2023 - mdpi.com
Simple Summary A proportion of patients with neuroendocrine tumours develop carcinoid
syndrome and subsequent carcinoid heart disease (CHD). Valve replacement is indicated …
syndrome and subsequent carcinoid heart disease (CHD). Valve replacement is indicated …
[PDF][PDF] Carcinoid Heart Disease–A 2022 Retrospective
CE Nistor, M Carsote, AE Ranetti… - Romanian Journal of - revistamedicinamilitara.ro
We aim to introduce a 2022 update on CHD (carcinoid heart disease) considering a
multidisciplinary perspective. This is a narrative mini-review. We searched English, full …
multidisciplinary perspective. This is a narrative mini-review. We searched English, full …
[引用][C] Le cœur carcinoïde: physiopathologie, diagnostic, pronostic et prise en charge
L François - Archives des Maladies du Coeur et des Vaisseaux …, 2023 - Elsevier